FUNDAPRES/CIMel

Buenos Aires B1824KAJ

0 studies enrolling now · 1 studies all time

What they study most

Diabetes Type 2

Studies at this site

• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up — Completed